Clinical Expansion Palladium is an automated PCR platform designed for rapid point-of-care infectious disease testing, positioning Integrated Nano-Technologies to serve hospitals, clinics, urgent care networks, reference laboratories, and mobile testing programs seeking faster turnaround and simplified workflows.

Diverse Markets Besides human healthcare, Palladium’s capabilities support food safety diagnostics, veterinary labs, and bio-threat detection, creating cross-sell opportunities with QA laboratories, animal health providers, food producers, and public health or government partners.

Growth Readiness As a late-stage company with growing revenue potential, INT can accelerate market penetration through OEM partnerships, regional distributors, and licensing deals with established diagnostics players, complemented by pilot deployments to demonstrate ROI and onboarding success.

Automation Edge The platform’s end-to-end automation—including sample preparation, nucleic acid amplification, and detection—delivers faster results, reduced manual labor, and easier operator training, a compelling case for hospital systems and reference labs evaluating throughput and labor costs.

Digital Enablement Leveraging cloud and data capabilities such as AWS and analytics, INT can offer data-driven service models, remote monitoring, and managed services to multi-site customers, enabling scalable subscriptions, service agreements, and post-sale support.